Abstract:ObjectiveTo summarize the surgical outcomes and clinical experience of surgical disease for patients having undergone orthotopic heart transplantation.MethodsFive cardiac transplant recipients requiring surgical management due to other surgical diseases including acute cholecystitis in 2 patients,acute appendicitis,bilateral mammary hypertrophy and lung tumor in 1 patients,respectively.The mean age of the entire group at the time of reoperation was 44.6 years(14-60 years) and the average time of operative procedures after transplant was 16.4 months(4-37 months).Four patients were treated with triple immunosuppression,including cyclosporine A(CsA) or tacrolimus,mycophenolate mofetil and corticosteroids,respectively.One patient received double-therapy of CsA and mycophenolate mofetil with early withdrawal of corticosteroids.All the acute cholecystitis and appendicitis patients underwent open cholecystectomy and appendectomy emergently.Reduction mammaplasty was performed on the bilateral mammary hypertrophy patients.For the lung tumor patient,right upper lobectomy and nodes excision were undertaken radically after the sample proved to be malignancy by the thoracoscopy.Closely surveillance at concentration of CsA or FK506 was performed continueously in order to adjust the effective blood concentration in a steady way by which acute rejection can be avoided.The pathways which pathogen organisms invading the human body were controlled strictly as well as intension on anti-infection treatment during perioperative period.ResultsFour patients discharged to home within 2 weeks.Only one patient needed further treatment in Digestive Department after emergent cholecystectomy due to gastric retention.And she was discharged after 66 days.No acute rejections or operative complications such as severe infection or bleeding were found during the perioperative period.The average length of stay was 21.3 days(8-66 days).During the follow-up from 1 month to 13 months,there was no relapse or allograft disfunction performed on any patients.All of them enjoy quality lives.ConclusionsMore attention should be paid to regular follow-up after transplantation,by which the emergent surgical diseases can be diagnosed and treated earlier and more effectively.Cardiac transplant recipients who subsequently require surgical intervention do quite well overall.Most of them can obtain excellent surgical outcomes.

Effect of basiliximab use on the risk of postoperative infection and death after heart transplantation: An observational study

Efficacy and Safety of Basiliximab in Liver Transplantation for Patients with Hepatitis B Virus-Related Diseases: A Single Centre Study

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

An Efficient Combination Immunotherapy for Antitumor Immunity Without Accelerating Cardiac Allograft Rejection.

Synergistic Effect of CsA and DBMC on Heterotopic Rat Cardiac Allograft Survival

The characters of infections after heart transplantation: prevention and management

A heart transplant center experience with basiliximab induction strategies: A double edged sword?

Effect of novel bicaval anastomosis technique for transplantation with and without prior cardiac surgery history

[Orthotopic Heart Transplantation: Clinical Experience on 56 Patients].

Preoperative examination of inflammatory biomarkers in relation to the prognosis of postoperative complications after heart transplantation

Issues of Immunological and Hemodynamic Monitoring Before and During Kidney Transplantation in Sensitized Heart Transplant Recipient

Abo-Incompatible Living Kidney Transplantation

Impact of combined heart and lung transplantation on bronchiolitis obliterans syndrome, cardiac allograft vasculopathy, and long-term survival

Modern advances in heart transplantation

Orthotopic Heart Transplantations for End-Stage Heart Diseases

Blood-based immunological monitoring after heart transplant. Current status and future prospects

Long-term results of 298 cases of orthotopic heart transplantations: a single center experience

Recipient hypertonic saline infusion prevents cardiac allograft dysfunction

Transplantation of a beating heart: A first in man

Ultrasound-targeted Sirolimus-Loaded Microbubbles Improves Acute Rejection of Heart Transplantation in Rats by Inhibiting TGF-β1-Smad Signaling Pathway, Promoting Autophagy and Reducing Inflammation

Surgical Procedures in Five Heart Transplant Patients